Peter Attia· MD
I'm more optimistic that biological aging or normative aging is going to be much more likely to translate to people both interventions and biomarkers than the specific disease interventions
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I'm more optimistic that biological aging or normative aging is going to be much more likely to translate to people both interventions and biomarkers than the specific disease interventions
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
I think aging is helping change that perspective that you know the the drivers of aging I think are very similar between a mouse and a human that the downstream events can be different uh but the drivers are what we care about right
So that's what I think aging is helping change that perspective that you know the the drivers of aging I think are very similar between a mouse and a human the the downstream events can be different.